These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7931229)

  • 1. Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?
    Lai CT; Zuo DM; Yu PH
    J Neural Transm Suppl; 1994; 41():221-9. PubMed ID: 7931229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
    J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
    Thiffault C; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):15-22. PubMed ID: 18771016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of metabolism on the MAO-B inhibitory potency of selegiline.
    Haberle D; Szökõ E; Magyar K
    Curr Med Chem; 2002 Jan; 9(1):47-51. PubMed ID: 11860347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short- and long-term (--)-deprenyl administration on mRNA for copper, zinc- and manganese-superoxide dismutase and glutathione peroxidase in rat brain.
    Kunikowska G; Gallagher I; Glover V; Clow A; Jenner P
    Brain Res; 2002 Oct; 953(1-2):1-11. PubMed ID: 12384232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice.
    Barber AJ; Yu PH; Boulton AA
    Life Sci; 1993; 53(9):739-47. PubMed ID: 8355573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells.
    Li XM; Juorio AV; Qi J; Boulton AA
    J Neurosci Res; 1998 Jul; 53(2):235-8. PubMed ID: 9671980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
    Seif-El-Nasr M; Atia AS; Abdelsalam RM
    Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake.
    Fang J; Yu PH
    Neuropharmacology; 1994 Jun; 33(6):763-8. PubMed ID: 7936114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-deprenyl (selegiline) limits the repetitive firing of action potentials in rat hippocampal CA1 neurons via a dopaminergic mechanism.
    Huang CC; Tsai JJ; Hsu KS
    Brain Res; 1997 Apr; 753(1):27-35. PubMed ID: 9125428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAO inhibitors and oxidant stress in aging brain tissue.
    Alper G; Girgin FK; Ozgönül M; Menteş G; Ersöz B
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):247-52. PubMed ID: 10208295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
    Dyck LE; Davis BA
    Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible inhibition of rat liver mitochondrial MAO A and MAO B by enantiomers of deprenyl and alpha-methylpargyline.
    Robinson JB; Bocchinfuso R; Khalil A
    J Pharm Pharmacol; 1995 Apr; 47(4):324-8. PubMed ID: 7791031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.